Active	Status	Sponsor type	Region	Phase	Filter
3 Active 0 Inactive 3 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

3 Trials

Active Trials   

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Sen, Arjune
NCT05814523: To Evaluate the Efficacy, Safety, and Tolerability of Intravenous Ganaxolone Added to Standard of Care in Refractory Status Epilepticus (RSE)	Withdrawn	3	70	Europe, RoW	Ganaxolone, Placebo, Standard of care	Marinus Pharmaceuticals	Refractory Status Epilepticus	08/24	08/24
ILiAD, NCT03489044 / 2016-003109-32: An Investigation of Levetiracetam in Alzheimer's Disease	Completed	2	8	Europe	Levetiracetam, Placebo Oral Tablet	University of Oxford, Oxford University Hospitals NHS Trust, Oxford Health NHS Foundation Trust, Northumberland, Tyne and Wear NHS Foundation Trust, UCB Pharma	Alzheimer Disease, Epilepsy	03/22	03/22
NCT05321641: Evaluation Of A Mobile Messaging Service In Improving Adherence Of Anti-Seizure Medications	Enrolling by invitation	N/A	1200	RoW	Mobile phone message reminders.	KEMRI-Wellcome Trust Collaborative Research Program, University of Oxford, African Population and Health Research Center	Epilepsy, Treatment Adherence	05/24	12/24